Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05674292 · ClinicalTrials.gov registry record · NA
An Evaluation of the Effect of the Erchonia Corporation Violet Zerona® Z6 for Body Contouring
A NA study of Circumference Reduction, sponsored by Erchonia Corporation.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
- 2
- Study locations
NCT05674292 is a NA study of Circumference Reduction that has completed, run by Erchonia Corporation. The registered enrollment target is 25 participants. The trial reports 2 study locations across 1 state.
The verdict
NCT05674292, a NA study of Circumference Reduction, has completed, sponsored by Erchonia Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this clinical study is to determine the effectiveness of the Erchonia® Violet Zerona Z6 (manufactured by Erchonia Corporation (the Company), an over-the-counter (OTC) laser device, in providing noninvasive body circumference reduction.
Conditions Studied
Interventions
- DEVICE Erchonia Violet Zerona Z6
Study Locations (2)
Michigan
- Tracey Hishon - Bloomfield Hills
- Jamie Thayer - Marquette
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2022-07-11 |
| Est. Completion | 2023-03-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05674292
The ClinicalTrials.gov registry entry for NCT05674292 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Erchonia Corporation, which has 34 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Circumference Reduction appearing as the primary indexed condition, and to 1 intervention - of which Erchonia Violet Zerona Z6 is the first listed.
NCT05674292 reports 2 study locations spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT05674292 about?
NCT05674292 is a clinical study titled "An Evaluation of the Effect of the Erchonia Corporation Violet Zerona® Z6 for Body Contouring". The purpose of this clinical study is to determine the effectiveness of the Erchonia® Violet Zerona Z6 (manufactured by Erchonia Corporation (the Company), an over-the-counter (OTC) laser device, in providing noninvasive body circumference reduction.
What is the current status of trial NCT05674292?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2022-07-11. Estimated completion is 2023-03-28.
What conditions does trial NCT05674292 study?
This clinical trial studies the following conditions: Circumference Reduction.
What interventions are being tested in trial NCT05674292?
The interventions under investigation include: Erchonia Violet Zerona Z6 (DEVICE).
Who is sponsoring clinical trial NCT05674292?
This trial is sponsored by Erchonia Corporation, which has 34 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05674292 being conducted?
This trial has 2 study locations across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.